Immune Thrombocytopenia — Microlearning Activity 1 with Dr Hanny Al-Samkari: ASH 2025 Review
From Hematologic Oncology Update by Dr. Neil Love
March 4, 2026 · 24 min · Season 25 · Episode 67
About this episode
Dr Hanny Al-Samkari discusses recent developments in the treatment of immune thrombocytopenia from the ASH 2025 Annual Meeting.
Dr Hanny Al-Samkari from Massachusetts General Hospital in Boston discusses recent developments from the ASH 2025 Annual Meeting involving the use of Bruton tyrosine kinase inhibitors and BAFF-R antagonists in the treatment of immune thrombocytopenia. CME information and select publications here .
People in this episode
Host: Dr. Neil Love
Guest: Dr Hanny Al-Samkari
Topics covered
- immune thrombocytopenia
- Bruton tyrosine kinase inhibitors
- BAFF-R antagonists
- ASH 2025
- recent developments
- treatment options
Keywords
- immune thrombocytopenia
- Bruton tyrosine kinase inhibitors
- BAFF-R antagonists
- ASH 2025
- CME information
- treatment
Mentioned in this episode
Organizations: Massachusetts General Hospital
Products: Bruton tyrosine kinase inhibitors, BAFF-R antagonists
More episodes of Hematologic Oncology Update
- Bruton Tyrosine Kinase Inhibitors for Chronic Lymphocytic Leukemia — Year in Review Series on Relevant New Datasets and Advances · May 23, 2026 · 59 min
- Acute Myeloid Leukemia — Year in Review Series on Relevant New Datasets and Advances · April 20, 2026 · 59 min
- CELMoDs for Multiple Myeloma — Microlearning Activity 2 with Dr Paul G Richardson · April 10, 2026 · 25 min
- Immune Thrombocytopenia — Microlearning Activity 4 with Dr Hanny Al-Samkari: ASH 2025 Review · April 1, 2026 · 25 min
- CELMoDs for Multiple Myeloma — Microlearning Activity 1 with Dr Paul G Richardson · March 23, 2026 · 24 min
- Immune Thrombocytopenia — Microlearning Activity 3 with Dr Hanny Al-Samkari: ASH 2025 Review · March 21, 2026 · 29 min
Explore listener stats, chart rankings, contacts and more on the Hematologic Oncology Update podcast page.